Survival in patients with gastric lymphoma

Authors

  • Asma Ouakaa-Kchaou Service de Gastro-entérologie Hôpital H. Thameur Tunis
  • Dalila Gargouri Service de Gastro-entérologie Hôpital H. Thameur Tunis
  • Héla Elloumi
  • Asma Kochlef
  • H Bouzid
  • Afef Kilani
  • Malika Romani
  • Jamel Kharrat
  • Abdeljabbar Ghorbel

Keywords:

Primary gastric lymphoma; survival; prognostic factors

Abstract

Background: Mucosa-associated lymphoid tissue lymphoma is a histological type of marginal zone non-Hodgkin's lymphoma. Its clinical features and prognosis have seldom been reported because of its indolent clinical course.
Aim: To establish prognostic factors that should be considered for the staging and management of this disease.
Methods: Clinical data of 40 pathologically confirmed gastric lymphoma patients, treated during a period of 13 years, were analyzed.
Results: Of the 40 patients, 65% had stage IE - II1E disease and 35% had stage II2E - IV disease. A total of 18 patients received surgeries.Eighteen patients had chemotherapy and 10 patients had Helicobacter Pylori eradication therapy. The complete remission rate after treatment was 50%. The patients were followed up for a median of 26.75 months. The 5-year overall survival rate was 70%. Early stage at presentation, surgery, normal lactic dehydrogenase (LDH) levels and Helicobacter Pylori infection were associated with longer survival in univariate analysis.
Conclusion: This study suggested that surgery might be an important factor predicting the long-term survival of patients with primary gastric lymphoma. Patients with poor prognostic factors should be treated more aggressively.

Downloads

Download data is not yet available.

References

Albujar P, Diaz J, Salinas E. Primary gastrointestinal lymphomas: clinical and pathological aspects and survival. Rev Gastroenterol 1995; 45: 832-45.

Brousse N. Le lymphome à petites cellules est-il un pseudolymphome, un lymphome ou une maladie infectieuse ? Ann Path 1994; 14: 206-8.

David L, Martin S, Daniel A. Long term follow-up after curative surgery for early gastric lymphoma. Ann Surg 1996; 223: 53-62.

Balfe P, O'Brian S, Daly P, Reynolds JV. Management of gastric lymphoma. Surgeon 2008; 6: 262-5.

Aozasa K, Ueda T, Kutata A. Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphoma. Cancer 1988; 20: 95-9.

Hoshida Y, Kusakabe H, Miwa H, Kasugai T, Ishiguro S. Reassessment of gastric lymphoma in light of the concept of mucosa associated lymphoid tissue lymphoma. Cancer 1997; 80: 1151-9.

Montalban C, Castrillo JM, Abraira V, Serrano M, Bellas C, Piris MA. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995; 6: 355-62.

Ruskone-Fourmestraux A, Pescatore P, Rambaud JC, Lavergne A, Colombel JF, Eugene C. Polypose lymphomateuse digestive. Gastroenterol Clin Biol 1992; 16: 649-55.

Sergui B, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterol 1991;101: 1159-70.

Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, Burgers JM. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high-grade malignancy in relation to the MALT concept. Gut 1996; 39: 556-61.

Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.

Chandran R, Hemanth R, Harit K, Chatur V. Primary gastrointestinal lymphoma: 30 years experience at the cancer institute, Madras, India. J Surg Oncol 1995; 60: 41-9.

Magid H, Akkad S. Gastrointestinal lymphoma in adults: Clinical features and management of 300 cases. Gastroenterol 1994; 106: 846-58.

Morton JE, Leyland HJ, Vaughan H. Primary gastrointestinal non Hodgkin's lymphoma a review of 175 British national lymphoma investigation cases. Br J Cancer 1993;67: 776-82.

Sperenza J, Loranto D, Lezoche E. Primary gastric lymphoma. Hepatogastroenterol 1995; 42: 371-6.

Akaza K, Motoori T, Nakamura S, Koshokawa T, Kitoh K, Futamira N. Clinicopathologic study of primary gastric lymphoma of B-cell phenotype with special reference to lox grade B-cell lymphoma of mucosa associated lymphoid tissue among the Japanese. Pathol Int 1995; 45: 832-45

Baldessera A, Perini F, Frezza G, Neri S. Combined treatment of stage I and II gastric lymphoma. Radio Med 1995; 89: 702-4.

Colucci G, Naglieri E, Maielle E, Marzullo F, Caruso ML, Leo S. Role of prognostic factors in the therapeutic strategy of primary gastric non-Hodgkin's lymphoma. Clin Ter 1998; 149: 25-30.

Flobert C, Cellier C, Landi B, Berger A, Palazzo L. Severe hemorrhagic gastritis of radiation origin. Gastroenterol Clin Biol 1998; 22: 232-4

Liang R, Tood D, Chan TK, Chiu E, Lie A, Kowng YL. Prognostic factors in primary gastrointestinal lymphoma. Hematol Oncol 1995; 13: 153-63.

Parilla P, Garcia-Marcilla JA, Alanso JD, Acosta J, Carrasco L, Sanchez-Bueno F. Prognostic factors in primary gastrointestinal non Hodgkin's lymphoma. Yonsei Med J 1998; 39: 763-7.

Pradella P, Maculotti L, Sesana G. Primary gastric lymphoma: 14 clinical cases. Minerva Chir 1995; 50: 637-41.

Richard K, Valicenti MD, Todd H, Wasserman MD, Kucik NA. Analysis of prognostic factors in localized lymphoma: the importance of Bulk of disease. Int J Rad Oncol Bio Phy 1993; 27: 591-8.

Yasushiro K, Shigo N, Yoshitaka Y. Primary gastric B-cell lymphoma: audit of 82 cases treated wtih surgery and classified according to the concept of mucosa-associated lymphoid tissue lymphoma. World J Surg 2000; 24: 857-62.

Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297-303

Rougier P, Azab M, Henry-Amar M, et al. Localisation digestive primitive des lymphomes malins non-Hodgkiniens. Facteurs pronostiques des formes localement étendues : stade II. A propos d'une série de 67 cas. Gastroenterol Clin Biol 1990;14: 626-34.

Walker DM, Freeze R, Roberts J. Treatment of gastric lymphoma. Am Surg 1992; 58: 409-12.

Raderer M, Paul De Boer J. Role of chemotherapy in gastric MALT lymphoma, diffuse large B-cell lymphoma and other lymphomas. Best Pract Res Clin Gastroenterol. 2010; 24: 19-26

Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 2000; 119: 1191-202.

Ruskone-Fourmestraux A, Aegerter P, Delmer A, Brousse N, Galian A, Rambaud JC. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 1993;105:1662-71.

Vaillant JC, Ruskone-Fourmestraux A, Aegerter P, et al. Management and long-term results of surgery for localized gastric lymphomas. Am J Surg 2000; 179: 216-22.

Danzon A, Belot A, Maynadié M, Remontet L, Dupont AC, Carbonnel F. Incidence and survival of gastric non-Hodgkin's lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM). Acta Oncol 2009;48: 977-83.

David SS, Daniel ED, Thomas A. Primary gastric lymphoma. An analysis with emphasis on prognostic factors and radiation therapy. Cancer 1983;52: 2044-8.

Downloads

Published

2011-10-27

Issue

Section

Original articles